| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CDC34 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | ERGIC2 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | CD55 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | NPIPB7 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | TRIM69 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | PPIH | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | WTH3DI | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | DCAF11 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | ZNF75A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | CYB561D1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
